# Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica

> **NCT04062006** · PHASE2 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT04062006
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-31
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04062006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04062006, "Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04062006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*